Evidence map›Paper›PMID 35413096›Full record

ArticleBlood advances2022

A complex proinflammatory cascade mediates the activation of HSCs upon LPS exposure in vivo.

Uta Margareta Demel, Raphael Lutz, Stefanie Sujer, Yasmin Demerdash, Shubhankar Sood, Florian Grünschläger, Andrea Kuck, Paula Werner, Sandra Blaszkiewicz, Hannah Julia Uckelmann and 2 more

Open access · goldAbstract read
In one paragraph

Article in Blood advances, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
3.8field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 2 countries.

Uta Margareta DemelDivision of Inflammatory Stress in Stem Cells, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Raphael LutzDivision of Inflammatory Stress in Stem Cells, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Stefanie SujerDivision of Inflammatory Stress in Stem Cells, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Yasmin DemerdashDivision of Inflammatory Stress in Stem Cells, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Shubhankar SoodDivision of Inflammatory Stress in Stem Cells, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Florian GrünschlägerHeidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGMBH), Heidelberg, Germany.ORCID 0000-0003-0021-6912
Andrea KuckDivision of Inflammatory Stress in Stem Cells, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Paula WernerDivision of Inflammatory Stress in Stem Cells, German Cancer Research Center (DKFZ), Heidelberg, Germany.ORCID 0000-0001-7419-1207
Sandra BlaszkiewiczDivision of Inflammatory Stress in Stem Cells, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Hannah Julia UckelmannDivision of Inflammatory Stress in Stem Cells, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Simon HaasDivision of Inflammatory Stress in Stem Cells, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Marieke Alida Gertruda EssersDivision of Inflammatory Stress in Stem Cells, German Cancer Research Center (DKFZ), Heidelberg, Germany.ORCID 0000-0003-3117-1809
German Cancer Research Center · DEBoston Children's Hospital · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Infections are a key source of stress to the hematopoietic system. While infections consume short-lived innate immune cells, their recovery depends on quiescent hematopoietic stem cells (HSCs) with long-term self-renewal capacity. Both chronic inflammatory stress and bacterial infections compromise competitive HSC capacity and cause bone marrow (BM) failure. However, our understanding of how HSCs act during acute and contained infections remains incomplete. Here, we used advanced chimeric and genetic mouse models in combination with pharmacological interventions to dissect the complex nature of the acute systemic response of HSCs to lipopolysaccharide (LPS), a well-established model for inducing inflammatory stress. Acute LPS challenge transiently induced proliferation of quiescent HSCs in vivo. This response was not only mediated via direct LPS-TLR4 conjugation on HSCs but also involved indirect TLR4 signaling in CD115+ monocytic cells, inducing a complex proinflammatory cytokine cascade in BM. Downstream of LPS-TLR4 signaling, the combined action of proinflammatory cytokines such as interferon (IFN)α, IFNγ, tumor necrosis factor-α, interleukin (IL)-1α, IL-1β, and many others is required to mediate full HSC activation in vivo. Together, our study reveals detailed mechanistic insights into the interplay of proinflammatory cytokine-induced molecular pathways and cell types that jointly orchestrate the complex process of emergency hematopoiesis and HSC activation upon LPS exposure in vivo.

Indexed as

LipopolysaccharidesToll-Like Receptor 4AnimalsCytokinesHematopoiesisHematopoietic Stem CellsMiceCytokinesLipopolysaccharidesToll-Like Receptor 4

Identifiers

PMID35413096
PMCPMC9198917
OpenAlexW4223484515

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.